JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
Dr. Reddy's Laboratories
RDY
$10.3B
| $44.4M | ﹤0.01% |
2,814,710
+311,095
| +12% | +$4.67M |
2019 Q3
21 quarters
|
|
1402
USA Compression Partners
USAC
$3.73B
| $44.3M | ﹤0.01% |
1,878,493
-1,336,085
| -42% | -$30.5M |
2022 Q4
8 quarters
|
|
1403
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.6B
| $44M | ﹤0.01% |
392,600
+58,200
| +17% | +$6.22M |
2023 Q4
4 quarters
|
|
1404
CareTrust REIT
CTRE
$8.57B
| $44M | ﹤0.01% |
1,628,012
-5,250,367
| -76% | -$157M |
2016 Q1
35 quarters
|
|
1405
Bunge Global
BG
$20.6B
| $44M | ﹤0.01% |
565,912
-192,714
| -25% | -$16.9M |
2013 Q2
46 quarters
|
|
1406
Merit Medical Systems
MMSI
$5.1B
| $43.9M | ﹤0.01% |
454,040
-121,906
| -21% | -$12.1M |
2016 Q2
34 quarters
|
|
1407
CALL
Caterpillar
CAT
$399B
| $43.9M | ﹤0.01% |
121,000
-23,000
| -16% | -$8.92M |
2020 Q3
17 quarters
|
|
1408
iShares S&P Small-Cap 600 Value ETF
IJS
$7.78B
| $43.9M | ﹤0.01% |
403,877
+32,581
| +9% | +$3.61M |
2013 Q2
46 quarters
|
|
1409
First Trust Smith Unconstrained Bond ETF
UCON
$3.19B
| $43.9M | ﹤0.01% |
1,778,924
+532,702
| +43% | +$13.2M |
2023 Q3
5 quarters
|
|
|
PR
1410
Permian Resources
PR
$18.7B
| $43.8M | ﹤0.01% |
3,043,717
-418,575
| -12% | -$6.07M |
2017 Q2
30 quarters
|
|
1411
First Solar
FSLR
$19.3B
| $43.7M | ﹤0.01% |
248,106
-1,484,926
| -86% | -$296M |
2013 Q2
46 quarters
|
|
1412
DraftKings
DKNG
$10B
| $43.6M | ﹤0.01% |
1,172,173
-1,397,599
| -54% | -$55.5M |
2020 Q2
18 quarters
|
|
1413
Matsons
MATX
$6.69B
| $43.6M | ﹤0.01% |
323,124
+36,156
| +13% | +$5.26M |
2013 Q2
46 quarters
|
|
1414
Cemex
CX
$14.1B
| $43.4M | ﹤0.01% |
7,697,251
-6,744,215
| -47% | -$38.3M |
2013 Q2
46 quarters
|
|
|
EDR
1415
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $43.3M | ﹤0.01% |
1,384,992
+1,051,942
| +316% | +$31.3M |
2021 Q2
14 quarters
|
|
1416
Zscaler
ZS
$34.2B
| $43.3M | ﹤0.01% |
239,859
-577,132
| -71% | -$112M |
2018 Q1
27 quarters
|
|
1417
Global X Artificial Intelligence & Technology ETF
AIQ
$10.6B
| $43.3M | ﹤0.01% |
1,119,815
+137,850
| +14% | +$5.3M |
2023 Q2
6 quarters
|
|
1418
PUT
American International
AIG
$39.7B
| $43.2M | ﹤0.01% |
594,000
+70,400
| +13% | +$5.29M |
2023 Q2
6 quarters
|
|
1419
FirstService
FSV
$5.64B
| $43.2M | ﹤0.01% |
238,471
+37,695
| +19% | +$7.05M |
2015 Q4
36 quarters
|
|
1420
nCino
NCNO
$2.03B
| $43.2M | ﹤0.01% |
1,285,258
-491,083
| -28% | -$18.3M |
2020 Q3
17 quarters
|
|
1421
GFL Environmental
GFL
$18.5B
| $43.1M | ﹤0.01% |
968,669
+152,072
| +19% | +$6.62M |
2020 Q3
17 quarters
|
|
1422
CALL
ConocoPhillips
COP
$155B
| $43.1M | ﹤0.01% |
434,750
-107,850
| -20% | -$11.5M |
2018 Q2
26 quarters
|
|
1423
iShares MSCI USA Value Factor ETF
VLUE
$9.54B
| $43.1M | ﹤0.01% |
407,952
+27,115
| +7% | +$2.98M |
2015 Q4
36 quarters
|
|
1424
A.O. Smith
AOS
$7.75B
| $43M | ﹤0.01% |
630,633
-104,360
| -14% | -$7.9M |
2013 Q2
46 quarters
|
|
1425
Vanguard Russell 1000 Growth ETF
VONG
$48.4B
| $42.9M | ﹤0.01% |
415,569
+112,977
| +37% | +$11.4M |
2015 Q3
37 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.